Factor assays are mainly undertaken during prolongation of the Activated Partial Thromboplastin Time (APTT) and Partial Thromboplastin Time (PTT) resulting in the deficiency of one or more clotting proteins. Overall a basic general principle is followed by all functional clotting factor assays that involves specific plotting/clotting time from either PTT or APTT depending on which factor it’s being assayed against sample dilution. A quantitative assay of an individual clotting factor is essential to identify inherited deficiency and to monitor replacement therapy and sometimes helps to distinguish acquired defects e.g. disseminated intravascular coagulation (DIC), vitamin K deficiency, inhibitors.
Forthcoming Market Structure of Factor Assays can be obtained at: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1867
Factor assay market can be broadly segmented on the basis of procedures and applications as follows:
Factor assay market, by procedures
> Factor II
> Factor V/Factor V Leiden
> Factor VII
> Factor VIII
> Factor IX
> Factor IXa
> Factor X (Stuart Factor)
> Factor Xa
> Factor XI
> Factor XII
> Factor XIII
Factor assay market, by applications
> Chromogenic substrates
> Monoclonal and Polyclonal antibodies
> DNA probes
> Artificial intelligence
> Dry chemistry
In a decade, it has been forecasted that growing cost pressures in major industrialized nations and continuous technological advances would drastically change coagulation testing practice. While automated instruments market would supplement the growth of factor assay market with new sensitive and specific markers of homeostasis. Opportunities for application of factor assays will increase mainly into quality control of products and services due to technological development and standardization of its various methods. Decentralization of the factor assay testing would occur due to continuous contraction of hospital system and technical advances that will create additional opportunities and challenges for suppliers.
North America is the largest factor assay market globally followed by Europe as most of the diagnostic testing is supplemented with technological superiority, R&D investment and increase in acceptance for time efficient testing techniques. Asia-Pacific is the growing market because of periodic shift of R&D functions from companies based in the U.S and Western Europe.
Some of the key players of this market are Abbott, Werfen Group (Instrumentation Laboratory), Avocet Medical, Inc., Beckman Coulter, Inc., Becton, Dickinson and Company, Helena Laboratories, HYPHEN BioMed, Hoffman-La Roche, Seimens AG, Trinity Biotech PLC and others.